Top

Critical Care

Published in:

Open Access 01-02-2014 | Research

Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review

Authors: Marcella C Müller, Joost CM Meijers, Margreeth B Vroom, Nicole P Juffermans

Published in: Critical Care | Issue 1/2014

Abstract

Introduction

Coagulation abnormalities are frequent in sepsis. Conventional coagulation assays, however, have several limitations. A surge of interest exists in the use of point-of-care tests to diagnose hypo- and hypercoagulability in sepsis.

We performed a systematic review of available literature to establish the value of rotational thromboelastography (TEG) and thromboelastometry (ROTEM) compared with standard coagulation tests to detect hyper- or hypocoagulability in sepsis patients. Furthermore, we assessed the value of TEG/ROTEM to identify sepsis patients likely to benefit from therapies that interfere with the coagulation system.

Methods

MEDLINE, EMBASE, and the Cochrane Library were searched from 1 January 1980 to 31 December 2012. The search was limited to adults, and language was limited to English. Reference lists of retrieved articles were hand-searched for additional studies. Ongoing trials were searched on http://www.controlled-trials.com and http://www.clinicaltrials.gov. Studies addressing TEG/ROTEM measurements in adult patients with sepsis admitted to the ICU were considered eligible.

Results

Of 680 screened articles, 18 studies were included, of which two were randomized controlled trials, and 16 were observational cohort studies. In patients with sepsis, results show both hyper- and hypocoagulability, as well as TEG/ROTEM values that fell within reference values. Both hyper- and hypocoagulability were to some extent associated with diffuse intravascular coagulation. Compared with conventional coagulation tests, TEG/ROTEM can detect impaired fibrinolysis, which can possibly help to discriminate between sepsis and systemic inflammatory response syndrome (SIRS). A hypocoagulable profile is associated with increased mortality. The value of TEG/ROTEM to identify patients with sepsis who could possibly benefit from therapies interfering with the coagulation system could not be assessed, because studies addressing this topic were limited.

Conclusion

TEG/ROTEM could be a promising tool in diagnosing alterations in coagulation in sepsis. Further research on the value of TEG/ROTEM in these patients is warranted. Given that coagulopathy is a dynamic process, sequential measurements are needed to understand the coagulation patterns in sepsis, as can be detected by TEG/ROTEM.

Available only for authorised users

Walsh TS, Stanworth SJ, Prescott RJ, Lee RJ, Watson DM, Wyncoll D: Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med 2010, 38: 1939-1946.PubMed

Levi M, Meijers JC: DIC: which laboratory tests are most useful. Blood Rev 2011, 25: 33-37. 10.1016/j.blre.2010.09.002CrossRefPubMed

Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Storkson R, Hervig T: Thrombelastography. Transfus Apher Sci 2009, 40: 119-123. 10.1016/j.transci.2009.01.019CrossRefPubMed

Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, Lakner M: Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinol 2005, 16: 301-310. 10.1097/01.mbc.0000169225.31173.19CrossRef

Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De DC, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003, 290: 238-247. 10.1001/jama.290.2.238CrossRefPubMed

Afshari A, Wetterslev J, Brok J, Moller A: Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. BMJ 2007, 335: 1248-1251. 10.1136/bmj.39398.682500.25PubMedCentralCrossRefPubMed

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed

Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Munoz A: Unfractioned heparin for treatment of sepsis: a randomized clinical trial (The HETRASE Study). Crit Care Med 2009, 37: 1185-1196. 10.1097/CCM.0b013e31819c06bcCrossRefPubMed

Adamzik M, Langemeier T, Frey UH, Gorlinger K, Saner F, Eggebrecht H, Peters J, Hartmann M: Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock 2011, 35: 339-342. 10.1097/SHK.0b013e318204bff6CrossRefPubMed

10.

Ostrowski SR, Windelov NA, Ibsen M, Haase N, Perner A, Johansson PI: Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. J Crit Care 2013, 28: 317.PubMed

11.

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155: 529-536. 10.7326/0003-4819-155-8-201110180-00009CrossRefPubMed

12.

A quality assessment tool for diagnostic accuracy studies: QUADAS-2: Background document via . accessed 5 June 2013 http://www.bris.ac.uk/quadas/quadas-2/ via . accessed 5 June 2013

13.

Hasegawa H: Estimation of coagulation-fibrinolytic factors in DIC. Bibl Haematol 1983, 49: 173-180.PubMed

14.

Clayton DG, Miro AM, Kramer DJ, Rodman N, Wearden S: Quantification of thrombelastographic changes after blood component transfusion in patients with liver disease in the intensive care unit. Anesth Analg 1995, 81: 272-278.PubMed

15.

Mohri M, Suzuki M, Sugimoto E, Sata M, Yamamoto S, Maruyama I: Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma. Thromb Haemost 1998, 80: 925-929.PubMed

16.

Baldwin I, Tan HK, Bridge N, Bellomo R: A prospective study of thromboelastography (TEG) and filter life during continuous veno-venous hemofiltration. Ren Fail 2000, 22: 297-306. 10.1081/JDI-100100873CrossRefPubMed

17.

Doria C, Mandala L, Smith JD, Caruana G, Scott VL, Gruttadauria S, Magnone M, Marino IR: Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004, 18: 365-371. 10.1111/j.1399-0012.2004.00172.xCrossRefPubMed

18.

Dunser MW, Fries DR, Schobersberger W, Ulmer H, Wenzel V, Friesenecker B, Hasibeder WR, Mayr AJ: Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? Anesth Analg 2004, 99: 201-206. 10.1213/01.ANE.0000118105.85933.8ACrossRefPubMed

19.

King DR, Cohn SM, Feinstein AJ, Proctor KG: Systemic coagulation changes caused by pulmonary artery catheters: laboratory findings and clinical correlation. J Trauma 2005, 59: 853-857. 10.1097/01.ta.0000187656.26849.39CrossRefPubMed

20.

Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care 2006, 10: R24. 10.1186/cc3985PubMedCentralCrossRefPubMed

21.

Nilsson CU, Hellkvist PD, Engstrom M: Effects of recombinant human activated protein C on the coagulation system: a study with rotational thromboelastometry. Acta Anaesthesiol Scand 2008, 52: 1246-1249. 10.1111/j.1399-6576.2008.01735.xCrossRefPubMed

22.

Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA: Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma 2009, 66: 1509-1515. 10.1097/TA.0b013e3181a51e33CrossRefPubMed

23.

Mineo G, Cascio ND, Canzio D, Marino L, Evangelico G, Cortegiani A, Raineri SM: Fondaparinux vs low molecular weight heparin as a thromboprophylaxis in critically ill patients: coagulation status monitored by thromboelastography [abstract]. Intensive Care Med 2009, Conference: S217.

24.

Sharma P, Saxena R: A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state. Am J Clin Pathol 2010, 134: 97-102. 10.1309/AJCPPZ4J6CAFYDVMCrossRefPubMed

25.

White H, Zollinger C, Jones M, Bird R: Can thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters? Int J Lab Hematol 2010, 32: 167-173. 10.1111/j.1751-553X.2009.01152.xCrossRefPubMed

26.

Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K: Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinol 2010, 21: 168-174. 10.1097/MBC.0b013e3283367882CrossRef

27.

Dimitrova-Karamfilova A: Thromboelastometry for the assessment of hypercoagulation in critically ill cardiac patients [abstract]. Transfusion Altern Transfus Med 2010, Conference: 37.

28.

Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, Ibrahim A, Lee WM, Sanyal AJ: Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 2012, 56: 129-136. 10.1016/j.jhep.2011.04.020CrossRefPubMed

29.

Agarwal B, Wright G, Gatt A, Riddell A, Vemala V, Mallett S, Chowdary P, Davenport A, Jalan R, Burroughs A: Evaluation of coagulation abnormalities in acute liver failure. J Hepatol 2012, 57: 780-786. 10.1016/j.jhep.2012.06.020CrossRefPubMed

30.

Ryan ML, Thorson CM, King DR, Van Haren RM, Manning RJ, Andrews DM, Livingstone AS, Proctor KG: Insertion of central venous catheters induces a hypercoagulable state. J Trauma Acute Care Surg 2012, 73: 385-390. 10.1097/TA.0b013e31825a0519CrossRefPubMed

31.

Wada H, Sakakura M, Kushiya F, Nisikawa M, Onishi K, Nakatani K, Shiku H, Nobori T: Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients. Blood Coagul Fibrinol 2005, 16: 17-24. 10.1097/00001721-200501000-00003CrossRef

32.

Picoli-Quaino SK, Alves BE, Aranha FJP, Lorand-Metze I, De Souza CA, Annichino-Bizzacchi JM, De Paula EV: Evaluation of thrombin generation in the early stages of sepsis in patients with hematological malignancies and febrile neutropenia [abstract]. ASH Conference Proceedings 2011, Conference: 3347.

33.

Soshitova NP, Karamzin SS, Balandina AN, Fadeeva OA, Kretchetova AV, Galstian GM, Panteleev MA, Ataullakhanov FI: Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics. Blood Coagul Fibrinol 2012, 23: 498-507. 10.1097/MBC.0b013e328352e90eCrossRef

34.

Baudo F, Caimi TM, DeCataldo F, Ravizza A, Arlati S, Casella G, Carugo D, Palareti G, Legnani C, Ridolfi L, Rossi R, D'Angelo A, Crippa L, Giudici D, Gallioli G, Wolfler A, Calori G: Antithrombin III (ATIII)) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med 1998, 24: 336-342. 10.1007/s001340050576CrossRefPubMed

35.

Galstyan GM, Krechetova AV, Alexanyan MG, Sinauridze EI, Gorodetsky VM, Vasiliev SA: Thrombin generation in patients (pts) with severe sepsis and septic shock during the treatment with high doses of antithrombin (AT) [abstract]. J Thromb Haemost 2009, Conference: 684.

36.

Tsen A, Kirschenbaum LA, Larow C, Khan R, Kurtz S, Bansal S, Astiz ME: The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic SHOCK. Shock 2009, 31: 120-124. 10.1097/SHK.0b013e318180ffe9CrossRefPubMed

37.

Ogawa Y, Yamakawa K, Ogura H, Kiguchi T, Mohri T, Nakamori Y, Kuwagata Y, Shimazu T, Hamasaki T, Fujimi S: Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis. J Trauma 2011, 72: 1150-1157.

38.

Durila M, Bronsky J, Harustiak T, Pazdro A, Pechova M, Cvachovec K: Biochemical and hematological parameters (including thromboelastography) differ in patients with sepsis and SIRS after esophagectomy. Crit Care 2011, 15: 443. 10.1186/cc10344CrossRef

39.

Raineri SM, Cangemi L, Cortegiani A, Cascio ND, Mineo G, Evangelico G, Giarratano A: Fibrinolysis system, monitored by thromboelastography (TEG) and PAI-1 activity, in septic patients undergoing tight glycemic control [abstract]. Intensive Care Med 2009, Conference: S162.

40.

Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC: Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006, 10: R160. 10.1186/cc5098PubMedCentralCrossRefPubMed

41.

Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH: Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinol 2009, 20: 419-426. 10.1097/MBC.0b013e32832a76e1CrossRef

42.

Viljoen M, Roux LJ, Pretorius JP, Coetzee IH, Viljoen E: Hemostatic competency and elastase-alpha 1-proteinase inhibitor levels in surgery, trauma, and sepsis. J Trauma 1995, 39: 381-385. 10.1097/00005373-199508000-00033CrossRefPubMed

43.

Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP: Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006, 135: 220-227. 10.1111/j.1365-2141.2006.06281.xCrossRefPubMed

44.

Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM: Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009, 13: R42. 10.1186/cc7765PubMedCentralCrossRefPubMed

45.

Umgelter A, Msmer G, Schmid RM, Kreymann B: Thromboelastography and platelet function assay in cirrhosis and sepsis [abstract]. Intensive Care Med 2009, Conference: S160.

46.

Schmittinger CA, Dunser MW, Torgersen C, Hasibeder WR, Luckner G, Mayr V, Jochberger S: Rotational thromboelastometry to assess the coagulation system in severe sepsis and the systemic inflammatory response syndrome: a prospective, controlled trial [abstract]. Intensive Care Med 2009, Conference: S162.

47.

Chiairi F, Ickx B, Barvais L, Vincent J-L, Piagnerelli M: Does activated protein C influence the coagulation system assessed by the rotative thromboelastometry analysis [abstract]. Intensive Care Med 2009, Conference: S162.

48.

Altmann DR, Korte W, Maeder MT, Fehr T, Haager P, Rickli H, Kleger GR, Rodriguez R, Ammann P: Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. Plos One 2010, 5: e9017. 10.1371/journal.pone.0009017PubMedCentralCrossRefPubMed

49.

Durila M, Kalincik T, Jurcenko S, Pelichovska M, Hadacova I, Cvachovec K: Arteriovenous differences of hematological and coagulation parameters in patients with sepsis. Blood Coagul Fibrinol 2010, 21: 770-774.CrossRef

50.

Adamzik M, Eggmann M, Frey UH, Gorlinger K, Brocker-Preuss M, Marggraf G, Saner F, Eggebrecht H, Peters J, Hartmann M: Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 2010, 14: R178. 10.1186/cc9284PubMedCentralCrossRefPubMed

51.

Cortegiani A, Marino L, Montalto F, Milana M, Di Benedetto A, Vento L, Raineri SM: Use of thromboelastography in severe sepsis: a case-control study [abstract]. Crit Care 2011, 15: 444. 10.1186/cc10439CrossRef

52.

Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A: Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Intensive Care Med 2012, 38: 1326-1335. 10.1007/s00134-012-2620-2CrossRefPubMed

53.

Durila M, Bronsky J, Harustiak T, Pazdro A, Pechova M, Cvachovec K: Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography). BMC Anesthesiol 2012, 12: 12. 10.1186/1471-2253-12-12PubMedCentralCrossRefPubMed

54.

Brenner T, Schmidt K, Delang M, Mehrabi A, Bruckner T, Lichtenstern C, Martin E, Weigand MA, Hofer S: Viscoelastic and aggregometric point-of-care testing in patients with septic shock: cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand 2012, 56: 1277-1290. 10.1111/j.1399-6576.2012.02750.xCrossRefPubMed

55.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644CrossRefPubMed

56.

Levi M, De JE, Van der Poll T: Sepsis and disseminated intravascular coagulation. J Thromb Thrombol 2003, 16: 43-47.CrossRef

57.

Schochl H, Solomon C, Schulz A, Voelckel W, Hanke A, Van GM, Redl H, Bahrami S: Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxinemia. Mol Med 2011, 17: 266-272.PubMedCentralCrossRefPubMed

58.

Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B: Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006, 4: 411-416. 10.1111/j.1538-7836.2006.01715.xCrossRefPubMed

59.

Zacharowski K, Sucker C, Zacharowski P, Hartmann M: Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 2006, 95: 557-561.PubMed

60.

Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86: 1327-1330.PubMed

61.

Thalheimer U, Triantos CK, Samonakis DN, Zambruni A, Senzolo M, Leandro G, Patch D, Burroughs AK: A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood. Blood Coagul Fibrinol 2008, 19: 495-501. 10.1097/MBC.0b013e3282f9adf9CrossRef

62.

Nielsen VG: A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinol 2007, 18: 247-252. 10.1097/MBC.0b013e328092ee05CrossRef

63.

Solomon C, Sorensen B, Hochleitner G, Kashuk J, Ranucci M, Schochl H: Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg 2012, 114: 721-730. 10.1213/ANE.0b013e31824724c8CrossRefPubMed

64.

Venema LF, Post WJ, Hendriks HG, Huet RC, de Wolf JT, de Vries AJ: An assessment of clinical interchangeability of TEG and RoTEM thromboelastographic variables in cardiac surgical patients. Anesth Analg 2010, 111: 339-344. 10.1213/ANE.0b013e3181e368bcCrossRefPubMed

65.

Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, Konrad I, Kennerknecht E, Reges K, Holdenrieder S, Braun S, Reinhardt C, Spannagl M, Preissner KT, Engelmann B: Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010, 16: 887-896. 10.1038/nm.2184CrossRefPubMed

Title: Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review
Authors: Marcella C Müller
Joost CM Meijers
Margreeth B Vroom
Nicole P Juffermans
Publication date: 01-02-2014
Publisher: BioMed Central
Published in: Critical Care / Issue 1/2014
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc13721

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review

Abstract

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults

Pharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children

Hypercapnia attenuates ventilator-induced diaphragm atrophy and modulates dysfunction

Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients

The role of thoracic epidural anesthesia in severe acute pancreatitis

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial